WilliamMMerhiDO
Cardiology • Grand Rapids, MIAdult Congenital Heart Disease, Interventional Cardiology, Cardiac Critical Care
Physician
Dr. Merhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
221 Michigan St NE
Ste 300
Grand Rapids, MI 49503Phone+1 616-391-9415Fax+1 616-885-5020
Education & Training
Corewell Health East Beaumont (Royal Oak)Fellowship, Interventional Cardiology, 2006 - 2007- Corewell Health East Beaumont (Royal Oak)Fellowship, Cardiovascular Disease, 2003 - 2006
- Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2000 - 2003
Michigan State University College of Osteopathic MedicineClass of 1999
Certifications & Licensure
MI State License 2000 - 2025- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 1 citationsUse and performance of the evolut FX transcatheter aortic valve system.Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams
Cardiovascular Revascularization Medicine. 2024-10-01 - Multidisciplinary Approach to Patent Foramen Ovale Closure for Cryptogenic Stroke: Brain-Heart Board Experience.Muhib Khan, Malgorzata Miller, Philip Mccarthy, Jenny P Tsai, William Merhi
Neurology. Clinical Practice. 2024-08-01 - 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.Firas Zahr, Basel Ramlawi, Michael J Reardon, G Michael Deeb, Steven J Yakubov
JACC. Cardiovascular Interventions. 2024-07-22
Journal Articles
- Original Investigation Self-Expanding Transcatheter Aortic Valve Replacement or Surgical Valve Replacement in High-Risk Patients: 5-Year OutcomesG Michael Deeb, Steven J Yakubov, Joon S Lee, Thomas G Gleason, William Merhi, George Petrossian, G Chad Hughes, David H Adams, Neal S Kleiman, Jeffrey J Popma, Mubash..., ScienceDirect
Press Mentions
Innovative Cardiovascular Solutions Raises $5M in New Angel Capital RoundJuly 23rd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
